
Keywords: CAP; community-acquired pneumonia; IRF5; interferon regulatory factor 5; TLR; Toll-like receptor; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells; IFNs; type I interferons; IL-6; interleukin-6; IL-12; interleukin-12; TNF-α; tumor n